On Thursday, Molson Coors announced a new strategic partnership with Fever-Tree in the U.S. set to begin on February 1.
According to a press release, Molson Coors will acquire an 8.5 percent stake in the U.K.-based non-alcoholic drinks brand as well as exclusive commercialization rights to Fever-Tree’s U.S. portfolio, which includes both carbonated drinks and cocktail mixers. Molson Coors states that the $88.3 million deal will allow it to bolster its Beyond Beer portfolio and support its premiumization strategy.
